Mauritania vs South Sudan: The number of people with susceptibility test result for rifampicin
Mauritania
0
in 2021
South Sudan
0
in 2021
Mauritania rank
146th
South Sudan rank
146th
The number of people with susceptibility test result for rifampicin over time
- Mauritania
- South Sudan
How they compare
Mauritania currently reports 0 against 0 in South Sudan, a difference of 0.
Across all 5 years both countries report, South Sudan has been ahead every year.
Mauritania ranks 146th and South Sudan ranks 146th of 155 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3 | 77.67 | 74.67 | South Sudan |
| 2020s | 0 | 164.5 | 164.5 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mauritania or South Sudan?
- Mauritania, at 0 against 0 in South Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mauritania and South Sudan?
- 0, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and South Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do Mauritania and South Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- Mauritania ranks 146th and South Sudan ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.